Clinical trial
Multicenter Randomized Controlled Study of Intravitreal Ranibizumab and Triamcinolone Acetonide Combination Therapy Versus Ranibizumab Monotherapy in Patients With Polypoidal Choroidal Vasculopathy
NCT02806752 is registered in ClinicalTrials.gov with Aier School of Ophthalmology, Central South University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multicenter Randomized Controlled Study of Intravitreal Ranibizumab and Triamcinolone Acetonide Combination Therapy Versus Ranibizumab Monotherapy in Patients With Polypoidal Choroidal Vasculopathy
- Lead sponsor
- Aier School of Ophthalmology, Central South University
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- January 31, 2017
- Completion date
- December 31, 2019
- Enrollment
- 120 (estimated)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.